Chubb Ltd. (0VQD)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 357.48 |
|---|---|
| 52-week range | 261.76 – 375.54 |
| Return, 1 month / 3 months | +4.9% / +1.8% |
| Return, 1 year / 3 years | +27.4% / +75.0% |
| Trend | Uptrend |
| RSI (14) | 75 |
| Volatility (1 year) | 19.4% |
| Worst drawdown (1 year) | -9.4% |
| Average daily value traded | 0.87M USD |
| Dividend yield | 1.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Chubb Ltd. is an insurance company that provides property and casualty coverage to businesses and individuals. Its commercial insurance serves companies of many sizes with cover for property, liability, marine, and specialty risks, while its personal lines offer home, auto, and accident insurance to households. The company also writes reinsurance and life insurance through its operations. Chubb is incorporated in Switzerland and maintains a substantial presence in the United States and other markets around the world.
On this site Chubb Ltd. appears as a stock on the London Exchange (UK), code 0VQD, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Chubb Ltd. (0VQD) trades on the London Exchange in UK. It last closed at USD 357.48 on 19 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 373 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 27.4% and over the last three months it rose 1.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 74 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.3% | ||
| From 52-week high | -1.3% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.8% | ||
| 6-month return | 9.9% | ||
| 12-month return, skipping the last month | 21.5% | ||
| Risk (lower is better) | 92 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility (1 year) | 19.4% | ||
| Worst drawdown (1 year) | -9.4% | ||
| Liquidity | 51 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.87M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.1% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Risk (lower is better): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +3.5% |
|---|---|
| 1 month | +4.9% |
| 3 months | +1.8% |
| 6 months | +9.9% |
| 1 year | +27.4% |
| 3 years | +75.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 340.91 / 329.95 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 10.95 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Sep 2026 | CHF 1.0200 |
| 11 Jun 2026 | CHF 1.0200 |
| 12 Mar 2026 | CHF 0.9700 |
| 11 Dec 2025 | CHF 0.9700 |
| 11 Sep 2025 | CHF 0.9700 |
| 12 Jun 2025 | CHF 0.9700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.